State Street Corp Coherus Bio Sciences, Inc. Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 2,226,851 shares of CHRS stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,226,851

Previous 2,177,031 2.29%

Holding current value

$2.05 Million

Previous $3 Million 39.98%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.81 - $1.66 $40,354 - $82,701	49,820 Added 2.29%	2,226,851 $1.8 Million
Q4 2024 Feb 14, 2025	BUY	$0.67 - $1.71 $100,968 - $257,695	150,699 Added 7.44%	2,177,031 $3 Million
Q3 2024 Nov 14, 2024	BUY	$0.99 - $1.8 $13,443 - $24,442	13,579 Added 0.67%	2,026,332 $2.11 Million
Q2 2024 Aug 14, 2024	BUY	$1.58 - $2.51 $26,883 - $42,707	17,015 Added 0.85%	2,012,753 $3.48 Million
Q1 2024 May 15, 2024	SELL	$2.02 - $3.14 $138,547 - $215,366	-68,588 Reduced 3.32%	1,995,738 $4.77 Million
Q4 2023 Feb 14, 2024	SELL	$1.59 - $3.85 $10.7 Million - $25.9 Million	-6,726,601 Reduced 76.52%	2,064,326 $6.87 Million
Q3 2023 Nov 14, 2023	BUY	$3.74 - $5.45 $23.3 Million - $34 Million	6,238,667 Added 244.44%	8,790,927 $32.9 Million
Q2 2023 Aug 14, 2023	SELL	$3.79 - $8.3 $13.4 Million - $29.4 Million	-3,545,323 Reduced 58.14%	2,552,260 $10.9 Million
Q1 2023 May 15, 2023	SELL	$5.89 - $10.52 $4.05 Million - $7.24 Million	-688,399 Reduced 10.14%	6,097,583 $41.7 Million
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $9.56 Million - $16.9 Million	1,680,211 Added 32.91%	6,785,982 $53.7 Million
Q3 2022 Nov 15, 2022	SELL	$7.17 - $13.87 $9.16 Million - $17.7 Million	-1,277,332 Reduced 20.01%	5,105,771 $49.1 Million
Q2 2022 Aug 15, 2022	BUY	$5.86 - $13.23 $7.14 Million - $16.1 Million	1,218,951 Added 23.6%	6,383,103 $46.2 Million
Q1 2022 May 16, 2022	BUY	$10.92 - $16.41 $14.7 Million - $22 Million	1,343,032 Added 35.15%	5,164,152 $66.7 Million
Q4 2021 Feb 14, 2022	SELL	$15.81 - $18.99 $3.36 Million - $4.04 Million	-212,586 Reduced 5.27%	3,821,120 $61 Million
Q3 2021 Nov 15, 2021	SELL	$12.68 - $17.79 $13.2 Million - $18.5 Million	-1,040,435 Reduced 20.5%	4,033,706 $64.8 Million
Q2 2021 Aug 16, 2021	BUY	$12.95 - $15.41 $3.13 Million - $3.73 Million	241,760 Added 5.0%	5,074,141 $70.2 Million
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $3.08 Million - $4.56 Million	213,331 Added 4.62%	4,832,381 $70.6 Million
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $5.38 Million - $6.15 Million	324,644 Added 7.56%	4,619,050 $80.3 Million
Q3 2020 Nov 10, 2020	SELL	$17.41 - $19.89 $15.4 Million - $17.5 Million	-881,740 Reduced 17.03%	4,294,406 $78.8 Million
Q2 2020 Aug 14, 2020	BUY	$14.43 - $19.16 $24.1 Million - $32.1 Million	1,673,152 Added 47.76%	5,176,146 $92.4 Million
Q1 2020 May 11, 2020	BUY	$11.67 - $22.53 $40.9 Million - $78.9 Million	3,502,994 New	3,502,994 $56.8 Million

Others Institutions Holding CHRS

# of Institutions

121

Shares Held

64.4M

Call Options Held

96.6K

Put Options Held

65.3K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $71.5M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Coherus Bio Sciences, Inc. Transaction History